Chapter/Section Purchase

1 Study Coverage
1.1 Oncology Injection Drug Product Introduction
1.2 Market by Type
1.2.1 Global Oncology Injection Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Organs
1.2.3 Central Nervous System
1.2.4 Circulatory/Musculoskeletal System
1.2.5 Other
1.3 Market by Application
1.3.1 Global Oncology Injection Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Lymphoma
1.3.3 Myeloma
1.3.4 Prostate Cancer
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oncology Injection Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Oncology Injection Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Oncology Injection Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Oncology Injection Drug Sales by Region
2.4.1 Global Oncology Injection Drug Sales by Region (2017-2022)
2.4.2 Global Sales Oncology Injection Drug by Region (2023-2028)
2.5 Global Oncology Injection Drug Revenue by Region
2.5.1 Global Oncology Injection Drug Revenue by Region (2017-2022)
2.5.2 Global Oncology Injection Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Oncology Injection Drug Sales by Manufacturers
3.1.1 Global Top Oncology Injection Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Oncology Injection Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oncology Injection Drug in 2021
3.2 Global Oncology Injection Drug Revenue by Manufacturers
3.2.1 Global Oncology Injection Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Oncology Injection Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Oncology Injection Drug Revenue in 2021
3.3 Global Oncology Injection Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Oncology Injection Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Oncology Injection Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oncology Injection Drug Sales by Type
4.1.1 Global Oncology Injection Drug Historical Sales by Type (2017-2022)
4.1.2 Global Oncology Injection Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Oncology Injection Drug Sales Market Share by Type (2017-2028)
4.2 Global Oncology Injection Drug Revenue by Type
4.2.1 Global Oncology Injection Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Oncology Injection Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Oncology Injection Drug Revenue Market Share by Type (2017-2028)
4.3 Global Oncology Injection Drug Price by Type
4.3.1 Global Oncology Injection Drug Price by Type (2017-2022)
4.3.2 Global Oncology Injection Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Oncology Injection Drug Sales by Application
5.1.1 Global Oncology Injection Drug Historical Sales by Application (2017-2022)
5.1.2 Global Oncology Injection Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Oncology Injection Drug Sales Market Share by Application (2017-2028)
5.2 Global Oncology Injection Drug Revenue by Application
5.2.1 Global Oncology Injection Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Oncology Injection Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Oncology Injection Drug Revenue Market Share by Application (2017-2028)
5.3 Global Oncology Injection Drug Price by Application
5.3.1 Global Oncology Injection Drug Price by Application (2017-2022)
5.3.2 Global Oncology Injection Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Oncology Injection Drug Market Size by Type
6.1.1 North America Oncology Injection Drug Sales by Type (2017-2028)
6.1.2 North America Oncology Injection Drug Revenue by Type (2017-2028)
6.2 North America Oncology Injection Drug Market Size by Application
6.2.1 North America Oncology Injection Drug Sales by Application (2017-2028)
6.2.2 North America Oncology Injection Drug Revenue by Application (2017-2028)
6.3 North America Oncology Injection Drug Market Size by Country
6.3.1 North America Oncology Injection Drug Sales by Country (2017-2028)
6.3.2 North America Oncology Injection Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Oncology Injection Drug Market Size by Type
7.1.1 Europe Oncology Injection Drug Sales by Type (2017-2028)
7.1.2 Europe Oncology Injection Drug Revenue by Type (2017-2028)
7.2 Europe Oncology Injection Drug Market Size by Application
7.2.1 Europe Oncology Injection Drug Sales by Application (2017-2028)
7.2.2 Europe Oncology Injection Drug Revenue by Application (2017-2028)
7.3 Europe Oncology Injection Drug Market Size by Country
7.3.1 Europe Oncology Injection Drug Sales by Country (2017-2028)
7.3.2 Europe Oncology Injection Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Oncology Injection Drug Market Size by Type
8.1.1 Asia Pacific Oncology Injection Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Oncology Injection Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Oncology Injection Drug Market Size by Application
8.2.1 Asia Pacific Oncology Injection Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Oncology Injection Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Oncology Injection Drug Market Size by Region
8.3.1 Asia Pacific Oncology Injection Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Oncology Injection Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Oncology Injection Drug Market Size by Type
9.1.1 Latin America Oncology Injection Drug Sales by Type (2017-2028)
9.1.2 Latin America Oncology Injection Drug Revenue by Type (2017-2028)
9.2 Latin America Oncology Injection Drug Market Size by Application
9.2.1 Latin America Oncology Injection Drug Sales by Application (2017-2028)
9.2.2 Latin America Oncology Injection Drug Revenue by Application (2017-2028)
9.3 Latin America Oncology Injection Drug Market Size by Country
9.3.1 Latin America Oncology Injection Drug Sales by Country (2017-2028)
9.3.2 Latin America Oncology Injection Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Oncology Injection Drug Market Size by Type
10.1.1 Middle East and Africa Oncology Injection Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Oncology Injection Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Oncology Injection Drug Market Size by Application
10.2.1 Middle East and Africa Oncology Injection Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Oncology Injection Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Oncology Injection Drug Market Size by Country
10.3.1 Middle East and Africa Oncology Injection Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Oncology Injection Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Taj Oncology
11.1.1 Taj Oncology Corporation Information
11.1.2 Taj Oncology Overview
11.1.3 Taj Oncology Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Taj Oncology Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Taj Oncology Recent Developments
11.2 S.G. Biopharm
11.2.1 S.G. Biopharm Corporation Information
11.2.2 S.G. Biopharm Overview
11.2.3 S.G. Biopharm Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 S.G. Biopharm Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 S.G. Biopharm Recent Developments
11.3 AdvaCare
11.3.1 AdvaCare Corporation Information
11.3.2 AdvaCare Overview
11.3.3 AdvaCare Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 AdvaCare Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 AdvaCare Recent Developments
11.4 Merrimack
11.4.1 Merrimack Corporation Information
11.4.2 Merrimack Overview
11.4.3 Merrimack Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Merrimack Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merrimack Recent Developments
11.5 Celgene
11.5.1 Celgene Corporation Information
11.5.2 Celgene Overview
11.5.3 Celgene Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Celgene Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Celgene Recent Developments
11.6 Allos Therapeutics
11.6.1 Allos Therapeutics Corporation Information
11.6.2 Allos Therapeutics Overview
11.6.3 Allos Therapeutics Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Allos Therapeutics Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Allos Therapeutics Recent Developments
11.7 Ferring Pharmaceuticals
11.7.1 Ferring Pharmaceuticals Corporation Information
11.7.2 Ferring Pharmaceuticals Overview
11.7.3 Ferring Pharmaceuticals Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Ferring Pharmaceuticals Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Ferring Pharmaceuticals Recent Developments
11.8 Genzyme
11.8.1 Genzyme Corporation Information
11.8.2 Genzyme Overview
11.8.3 Genzyme Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Genzyme Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Genzyme Recent Developments
11.9 Eli Lilly
11.9.1 Eli Lilly Corporation Information
11.9.2 Eli Lilly Overview
11.9.3 Eli Lilly Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Eli Lilly Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Eli Lilly Recent Developments
11.10 Praecis Pharmaceuticals
11.10.1 Praecis Pharmaceuticals Corporation Information
11.10.2 Praecis Pharmaceuticals Overview
11.10.3 Praecis Pharmaceuticals Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Praecis Pharmaceuticals Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Praecis Pharmaceuticals Recent Developments
11.11 Millennium Pharmaceuticals
11.11.1 Millennium Pharmaceuticals Corporation Information
11.11.2 Millennium Pharmaceuticals Overview
11.11.3 Millennium Pharmaceuticals Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Millennium Pharmaceuticals Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Millennium Pharmaceuticals Recent Developments
11.12 Debiopharm
11.12.1 Debiopharm Corporation Information
11.12.2 Debiopharm Overview
11.12.3 Debiopharm Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Debiopharm Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Debiopharm Recent Developments
11.13 Alza
11.13.1 Alza Corporation Information
11.13.2 Alza Overview
11.13.3 Alza Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Alza Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Alza Recent Developments
11.14 CordenPharma
11.14.1 CordenPharma Corporation Information
11.14.2 CordenPharma Overview
11.14.3 CordenPharma Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 CordenPharma Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 CordenPharma Recent Developments
11.15 Pharmascience
11.15.1 Pharmascience Corporation Information
11.15.2 Pharmascience Overview
11.15.3 Pharmascience Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Pharmascience Oncology Injection Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Pharmascience Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oncology Injection Drug Industry Chain Analysis
12.2 Oncology Injection Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oncology Injection Drug Production Mode & Process
12.4 Oncology Injection Drug Sales and Marketing
12.4.1 Oncology Injection Drug Sales Channels
12.4.2 Oncology Injection Drug Distributors
12.5 Oncology Injection Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Oncology Injection Drug Industry Trends
13.2 Oncology Injection Drug Market Drivers
13.3 Oncology Injection Drug Market Challenges
13.4 Oncology Injection Drug Market Restraints
14 Key Findings in The Global Oncology Injection Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer